James N Olson

6482223, Nov 19, 2002

Jun 1, 2000

09/585488

Karol L. Nowakowski - Circle Pines MN
James E. Olson - Eagan MN
Edward T. Joseph - Inver Grove Heights MN
Daniel G. Ericson - Rochester MN

Closys Corporation - Edina MN

A61B 1704

606213, 424530, 210782, 210651, 422 44

Wound closure methods and apparatus are provided which utilize blood fluid by activating the clotting cascade of blood fluid outside the body within a substantially enclosed sterile container then introducing the blood fluid to the wound site to complete clotting. Methods and apparatus for providing ways of inhibiting anti-coagulating agents and slowing fibrin clot degradation are also disclosed. Kits for practicing the invention singularly or in combination with and/or associated with preferred procedures are also disclosed. The present invention provides improved methods of creating hemostasis or control of bleeding at the site of wounds, particularly wounds created in arteries during procedures employing percutaneous access. The invention preferably includes the steps of acquiring an aliquot of a patients blood, i. e. , autologous blood, removing a negatively charged anti-coagulating agent, preferably heparin, from the blood, and preferably initiating the bloods natural clotting cascades and transporting the thus treated blood to the site of the wound where the clotting cascade will be completed producing a clot at the wound site that will create a condition of hemostasis.

6569517, May 27, 2003

Nov 17, 2000

09/714932

Daniel J. McGurran - Woodbury MN
Laurence R. Gilbert - Marine on St. Croix MN
Bryan L. Klaenhammer - River Falls WI
James A. Olson - Maplewood MN

3M Innovative Properties Company - St. Paul MN

B32B 516

428323, 359582, 359585, 359589, 428328, 428336, 428337, 428458

A color-tailorable, surface-metalized, pigmented optical body comprising a single or multiple layer polymeric core comprising at least one layer of a thermoplastic polymer material having dispersed therein a particulate pigment, and a metallic layer located on at least one outer surface of the polymeric core. The optical bodies are generally constructed such that the at least one of the L*, a*, and b* color scales of the polymeric core differs from the L*, a*, and b* color scales of the metallic layer.

6811867, Nov 2, 2004

Aug 8, 2000

09/633911

Daniel J. McGurran - Woodbury MN
Robert L. Brott - Woodbury MN
James A. Olson - Maplewood MN

3M Innovative Properties Company - St. Paul MN

B32B 2718

428323, 428328, 428329, 428330, 428331, 428480, 359885

Color-stable, pigmented optical bodies comprising a single or multiple layer core having at least one layer of a thermoplastic polymer material. The thermoplastic polymer material has dispersed within it a particulate pigment. The optical bodies generally possess high clarity and low haze and exhibit a transmission of light within a wavelength band of interest within the visible spectrum of from about 10 to about 90 percent.

7368161, May 6, 2008

Aug 23, 2004

10/923901

Daniel J. McGurran - Woodbury MN, US
Robert L. Brott - Woodbury MN, US
James A. Olson - Maplewood MN, US

3M Innovative Properties Company - St. Paul MN

B32B 27/18
B32B 27/20
B32B 27/36

428215, 428212, 428213, 428323, 428332, 428334, 428337, 428339, 428480, 428910, 359885

Color-stable, pigmented optical bodies comprising a single or multiple layer core having at least one layer of a thermoplastic polymer material. The thermoplastic polymer material has dispersed within it a particulate pigment. The optical bodies generally possess high clarity and low haze and exhibit a transmission of light within a wavelength band of interest within the visible spectrum of from about 10 to about 90 percent.

7469274, Dec 23, 2008

Dec 19, 2003

10/742221

Sung-Wook Ryu - Mountain View CA, US
James Olson - Fridley MN, US
William Kawakami - Belmont CA, US
Andrew Roe - St. Paul MN, US

Symantec Operating Corporation - Cupertino CA

G06F 13/00

709214

Systems, methods, apparatus and software can be implemented to discover third-party copy devices in a distributed computing environment, determine which of the third-party copy devices is best suited for a particular data moving application, and thereby better utilize network and computing system resources. Moreover, environment changes (e. g. , device failure, network traffic changes, new device addition) can be dynamically incorporated into the information used for third-party copy device discovery and selection. These systems, methods, apparatus and software help to reduce human errors which can cause failures in critical data protection operations.

8282620, Oct 9, 2012

Feb 5, 2009

12/366165

James M. Olson - Plymouth MN, US
Michael Hegland - Mounds View MN, US
Dale F. Seeley - Spring Park MN, US

Medtronic, Inc. - Minneapolis MN

A61B 19/00
B65B 1/04
B65B 3/04

604408, 604403, 141 10

A container for housing a fluid therapeutic composition includes a rigid housing, a collapsible bag and a seal. The housing has an opening and an interior surface. The interior surface forms a cavity having a volume. The bag is disposed in the housing and is expandable to contact the interior surface of the housing and occupy the entire volume of the cavity when filled with the fluid therapeutic composition. The bag has an opening that is fixed in proximity to the opening of the housing. The seal is configured to prevent air from entering the bag via the bag opening and to prevent air from entering the cavity of the housing via the housing opening.

8343084, Jan 1, 2013

Oct 29, 2010

12/915822

Karol L. Nowakowski - Circle Pines MN, US
James E. Olson - Eagan MN, US
Edward T. Joseph - Inver Grove Heights MN, US
Daniel G. Ericson - Rochester MN, US

Closys Corporation - St. Paul MN

A61M 37/00
A61M 31/00
A61B 19/00
A61K 31/74
A61K 47/48

604 401, 604 501, 604 607, 604 609, 604 612, 604 615, 604 616, 604522, 604403, 424 7808, 424 7809, 424 781, 424 7817, 424 7826

A wound closure apparatus and associated methods are provided which utilize blood fluid by activating the clotting cascade of blood fluid within a substantially enclosed sterile container then introducing the blood fluid to the wound site to complete clotting. An apparatus for providing ways of inhibiting anticoagulating agents and slowing fibrin clot degradation are also disclosed. Kits are also disclosed. The invention provides a clotting cascade initiation apparatus including a substantially enclosed sterile containment chamber within which an aliquot of blood fluid, either autologous or from donor sources, can be received and retained. In preferred embodiments, the sterile containment chamber further includes a heparin binding agent which will bind heparin and remove it from the blood fluid. In further embodiments, the containment chamber will also include a procoagulating agent, wherein a clotting cascade can be initiated when the blood fluid is accepted into the sterile containment chamber.

20030017326, Jan 23, 2003

Jun 1, 2001

09/872532

Daniel McGurran - Woodbury MN, US
James Olson - Maplewood MN, US
Mark Schaeffer - Hudson WI, US

3M Innovative Properties Company

B32B005/16
B32B027/36

428/323000, 428/328000, 428/329000, 428/331000, 428/480000

Color-stable, pigmented optical bodies comprising a single or multiple layer core having at least one layer of a thermoplastic polymer material. The thermoplastic polymer material has dispersed within it a particulate pigment. The optical bodies generally possess high clarity and low haze and exhibit a transmission of light within a wavelength band of interest within the visible spectrum of from about 10 to about 90 percent. The optical bodies also comprise one or more dyes in an amount sufficient to adjust transmitted color, by no more than about 15 units of the color coordinate a* and no more than about 15 units of the color coordinate b*, to a target color such as neutral gray.